Sesn2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
**Full Name:** Sestrin 2
**Chromosomal Location:** 1p35.3
**NCBI Gene ID:** 83667
**OMIM:** 607336
**Ensembl ID:** ENSG00000140299
**UniProt:** Q9Y7X7
**Associated Diseases:** Alzheimer's Disease, Parkinson's Disease, Metabolic Syndrome, Cancer
SESN2 (Sestrin 2) is a stress-inducible protein that functions as a critical regulator of cellular homeostasis, metabolic adaptation, and stress resistance. It is the most studied member of the sestrin family and is activated by various stressors including oxidative stress, DNA damage, and hypoxia. SESN2 has emerged as an important protective factor in neurodegenerative diseases through its regulation of mTOR signaling, AMPK activation, and antioxidant defense.
SESN2 performs multiple protective cellular functions:
- mTORC1 Inhibition: Binds to GATOR2 complex to suppress mTORC1 signaling
- AMPK Activation: Activates AMPK to promote catabolism and inhibit anabolism
- Autophagy Induction: Promotes autophagy through mTOR inhibition
- Antioxidant Defense: Induces NRF2-mediated antioxidant gene expression
- Mitophagy: Helps clear damaged mitochondria
- p53 Regulation: Induced by p53 in DNA damage response
SESN2 is protective in AD:
- mTOR hyperactivation contributes to Aβ accumulation
- SESN2 promotes autophagy to clear Aβ
- Reduces oxidative stress in neurons
- May protect synaptic function
SESN2 protects dopaminergic neurons:
- Promotes mitophagy to clear damaged mitochondria
- Protects against 6-OHDA and MPTP toxicity
- Reduces oxidative stress
- May help clear α-synuclein aggregates
- Improves insulin sensitivity
- Protects against obesity
- Benefits metabolic function
SESN2 is widely expressed:
- Highest expression in muscle and liver
- Brain: cortex, hippocampus, cerebellum
- Strongly induced by stress
- HIF-1α regulated under hypoxia
- "Sestrin2 is a p53-inducible gene" - Oncogene (2002) - DOI:10.1038/sj.onc.1205383
- "Sestrin2 inhibits mTORC1" - Cell (2012) - DOI:10.1016/j.cell.2012.06.024
- "Sestrin2 and mitophagy" - Autophagy (2018) - DOI:10.1080/15548627.2018.1474995
| Agent |
Mechanism |
Development Stage |
Notes |
| Sestrin2 activators |
Increase activity |
Discovery |
Novel target |
| mTOR inhibitors |
Indirect Sestrin2 effect |
Various |
Rapamycin etc. |
| Antioxidants |
NRF2 activation |
Various |
Indirect |
The study of Sesn2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Budanov AV et al. (2002). Sestrin2 is p53-regulated. Oncogene. PMID:11953230
- Peng Y et al. (2018). Sestrin2 and mitophagy. Autophagy. PMID:29484939
- Kimball SR et al. (2019). Sestrin2 in metabolism. Am J Physiol. PMID:30798552